The human microbiota consists of the trillions of symbiotic microbial
The global Human Microbiome Market size is projected to reach a CAGR of 31.07% from 2023-2030.
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person mainly bacteria in the gut. Microbes, including bacteria, fungi, and viruses, are disease-causing agent that accumulates over time, and the habitat in the gut transforms their genetic activities and metabolic processes, resulting in an abnormal immune response against the substances and tissues that are normally present in the human body.
Get Free Sample Report@ https://www.delvens.com/get-free-sample/human-microbiome-market
Several microbiome projects have been launched worldwide with the aim to understand the roles played by these symbionts and their impact on the health of human hosts.
Human gut microbiomes play a major role in improving the efficacy of therapeutic compounds. Over the years, studies have shown that the right combination of microbes in the human body is beneficial for treating different conditions.
Recent Developments
In 2022, OptiBiotix Health Plc. signed an exclusive sales and distribution agreement with Nahdi Medical Co. To help tackle the obesity epidemic, the company’s GoFigure and SlimBiome Medical weight management products will be available in the KSA from early 2022 through the new agreement with Nahdi.
In September 2021, PhenoBiome today launched a human gut microbiome assay through Genetic Direction, which will process the assays in its CLIA- and CAP-certified laboratory.
Prominent Players
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Kaleido
- Seres Therapeutics
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/human-microbiome-market
Asia Pacific to Dominate the Market
The Human Microbiome Market in Asia Pacific is estimated to expand at a rapid pace during the forecast period. This expansion of the market in Asia Pacific can be attributed to the high rate of adoption of autonomous forklifts in countries, such as China, which produced maximum number of vehicles across the globe.
Development of infrastructure and rapid industrialization coupled with expansion of construction and transportation industries are likely to boost the Human Microbiome Market in India and consequently, propel the Human Microbiome Market in Asia Pacific.
Human Microbiome Market Segmentation:
On the basis of product
· Probiotics
· Prebiotics
· Diagnostic Tests
· Drugs
· Other Products
On the basis of disease
· Infectious Diseases
· Endocrine and Metabolic Disorders
· Gastrointestinal Diseases
· Cancer
On the basis of application
· Therapeutics
· Diagnostics
On the basis of type
· FMT
· Peptide
· Live Biotherapeutic Product
· Others
On the basis of technology
· Genomics
· Proteomics
· Metabolomics
Based on region:
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Get Detailed Report: https://www.delvens.com/report/human-microbiome-market
Frequently Asked Questions
· What are the years considered to study Human Microbiome Market?
· What is the compound annual growth rate (CAGR) of the Human Microbiome Market?
· Which region holds the largest market share in Human Microbiome Market?
· Who are the major players in Human Microbiome Market?
In addition to the market data for Human Microbiome Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.
More Related Reports:
Human Organoids Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
Comments
0 comment